Considerable uncertainty surrounds the stoichiometry of coupling of ATP hydrolysis to drug pumping by P-glycoprotein, the multidrug transporter. To estimate relative turnovers for pumping of the drug vinblastine and ATP hydrolysis, we began by measuring the number of P-glycoprotein molecules on the surface of murine NIH3T3 cells expressing the human MDR1 gene. Fluorescence of cells treated with monoclonal antibody UIC2 was determined as a function of (i) amount of antibody at a fixed number of cells and (ii) increasing cell number at constant antibody. The two together gives 1.95 ؋ 10 6 P-glycoprotein molecules/cell. Initial uptake rates of vinblastine ؎ verapamil measure the ability of P-glycoprotein to extract vinblastine from the plasma membrane before it enters the cell. As a function of [vinblastine] , a turnover number of 1.4 s ؊1 . The vinblastinestimulated ATPase activity of P-glycoprotein has a turnover number of 3.5 s ؊1 at 37°C, giving 2.8 molecules of ATP hydrolyzed for every vinblastine molecule transported in a particular direction. These calculations involve several approximations, but turnover numbers for pumping of vinblastine and for vinblastine-stimulated ATP hydrolysis are comparable. Thus, ATP hydrolysis is probably directly linked to drug transport by P-glycoprotein.
Most people who die from cancer do so because their tumors have metastasized and become resistant to chemotherapy. Until we find ways to prevent cancer entirely, overcoming drug resistance is the main hope to save lives. P-glycoprotein (Pgp), 1 the product of the MDR1 gene, contributes to multidrug resistance in many cell types (1, 2) and is expressed in many tumors (3) (4) (5) (6) (7) (8) . P-gp pumps out its drug substrate from the tumor cell, reducing the effectiveness of administered chemotherapeutic agents (9) . It has ATPase (10 -14) activity enhanced by numerous substrates and substrate analogs. A very wide range of substrates are pumped out of cells by P-gp (15) . Major efforts have been made toward finding clinically useful reversers of P-gp that can block its action, leading to renewed accumulation of drugs within erstwhile resistant cells (16 -17) . Secure knowledge of the mechanism of action of P-gp is the basis for designing new and more effective reversers.
Four lines of evidence indicate that P-gp can expel its substrates directly out of the cell membrane (reviewed in Ref. 18 ). First, the substrates of P-gp are lipophilic and reside, most of the time, within cell membranes. Thus, it is within the membrane that the pump will find it most easy to locate its substrate. Second, kinetic analyses show that drug accumulation is reduced by the action of P-gp from the earliest times that measurements can be made, i.e. before significant amounts of the drug can enter the cell yet when it is already present within the membrane (19) . Hence it seems to be pumped out from the membrane itself before it crosses it. Third, Raviv et al. (20) , making use of the ability of the photosensitive probe 5-iodonaphthalene-1-azide to label membrane proteins, showed that doxorubicin was expelled from cell membranes of P-gpcontaining but not drug-sensitive cells. In addition, fluorescent dyes such as Hoechst 33342 (21) and calcein-AM (22) have been used to demonstrate removal of substrate from the lipid bilayer by P-gp. These considerations favor a "vacuum cleaner" model (20) for P-gp in which this protein is an ATP-driven pump that pumps its substrates directly out of the plasma membrane. A major criticism of this model is, however, the lack of reliable information on the stoichiometry of ATP hydrolysis to drug pumping. Attempts to measure this stoichiometry in phospholipid vesicles containing pure P-gp suggested a minimum of 50 ATP molecules hydrolyzed per drug molecule transported, however, such a figure is difficult to reconcile with the metabolic potential of multidrug resistant cells (12) . Recently, Eytan et al. (23) attempted to derive the stoichiometry by measuring the effect of P-gp on valinomycin-facilitated transport of 86 Rb ϩ into proteoliposomes containing P-gp, valinomycin being a P-gp substrate. They reported 0.5-0.8 molecules of the complex valinomycin-Rb ϩ transported for every ATP molecule hydrolyzed. They assumed, however, that only Rb ϩ -complexed valinomycin molecules were transported by P-gp, whereas we observed 2 that valinomycin's stimulation of ATP hydrolysis by P-gp is unaffected by its charged state. Transport of charged valinomycin molecules in the experiments by Eytan et al. (23) was carried out in the presence of a substantial excess of the uncharged form, which would not contribute to the measured flux but would contribute to ATP hydrolysis. In addition, their assay was carried out in solutions that were not free of potassium, which would compete with rubidium, complicating their calculations of the stoichiometry. We deemed it important, therefore, to determine this stoichiometry using an independent approach.
Here we determine the number of P-gp molecules present on the surface of P-gp-expressing cells using an antibody (Ab) titration procedure and FACS analysis. In the same cell type, we measure the maximum capacity of P-gp to reduce the entry of its substrate vinblastine (VBL) by determining the difference between initial rates of VBL uptake in the presence and absence of the P-gp blocker verapamil. These two numbers, taken together, can determine the catalytic constant (molecules pumped per second) for the effect of P-gp on reducing VBL accumulation. Also, we measure the maximum capacity of such cells to accelerate efflux of loaded VBL in the presence of an energy source, giving another measure of the transport capacity and of the catalytic constant for the effect of P-gp on VBL transport. Comparing these catalytic constants with that obtained for the effect of VBL on accelerating ATP hydrolysis by P-gp, we compute the ratio of the maximum rate of VBL transport to the maximum rate of VBL-stimulated ATP hydrolysis. This ratio is not far from unity. Thus, only a small number of ATP molecules seem hydrolyzed for each VBL molecule transported by P-gp.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture-We used the following previously characterized murine NIH3T3 fibroblasts: sensitive cells (NIH3T3 cell line), wild type human P-gp-expressing MDR1-Gly-185, and mutant MDR1-Val-185 (in which glycine at position 185 is substituted by valine) as described in Stein et al. (19) . Human MDR1-transfected cell lines N3-30, N3-600, and N3-2400 (resistant to vincristine at 30, 600, and 2400 ng/ml, respectively) were characterized by Germann et al. (24) . Cells were grown as monolayer cultures as described earlier (19, 24) .
FACS Analysis-0.125 to 8 million cells (from a 10-cm dish harvested by trypsinization into PBS, washed twice with PBS containing 0.1% bovine serum albumin (PBS-BSA), and resuspended in PBS-BSA) were incubated for 30 min on ice with 0.125-6.4 g of human P-gp-specific UIC2 monoclonal Ab (Immunotech, Westbrook, ME) (25) or with 5 g of IgG2a isotype control Ab (PharMingen), washed twice with PBS-BSA, and reacted with fluorescein-conjugated (fluorescein isothiocyanatelabeled) goat anti-mouse IgG2a Ab (1-10 g; Jackson ImmunoResearch Laboratories, West Grove, PA) for 30 min on ice. The cells were again washed twice in PBS-BSA and the levels of FL1 fluorescence were analyzed using a FACSort flow cytometer with Cell Quest software (Becton Dickinson FACS System, San Jose, CA).
Transport Experiments-Cells were seeded onto 5-cm dishes at 400,000 cells/2 ml of complete medium (in the absence of cytotoxic drugs) and used 2 days later at 10 6 cells/dish after washing in ice-cold PBS. Uptake was measured from 5 s to 120 min at 37°C from PBS containing 5 mM glucose and 15-25 Ci/mmol 3 H-VBL (Amersham) at concentrations from 1.4 nM to 80 M and either 0 or 50 M verapamil (to block P-gp), and stopped by washing rapidly, twice, in ice-cold PBS. Zero time uptakes were determined by adding ice-cold solutions of the 3 H-VBL to the cells. Cells were removed from dishes by trypsinization, and dish contents were transferred to vials for liquid scintillation counting. Cells from dishes (PBS-washed as for the transport experiments) were trypsinized for counting in the hemocytometer. For efflux, cells were first loaded with VBL by suspending in appropriate concentrations of 3 H-VBL for 40 min at 25°C from PBS containing 10 mM sodium azide and 10 mM 2-deoxyglucose to deprive the cells of metabolic energy (and block the action of P-gp). Efflux was initiated after washing cells rapidly in PBS followed by resuspension in PBS containing either sodium azide and 2-deoxyglucose as before or 5 mM glucose. Efflux was terminated by washing the dish rapidly with ice-cold PBS, and cells were taken for scintillation counting as before. Data are reported in terms of the volume of external solution taken up by, or still remaining in, 1 million cells at the reported time (19) . In all cases aliquots of the 3 H-VBL solutions used were taken for scintillation counting to calculate this quantity.
ATP Hydrolysis Assays-ATP hydrolysis by crude cell membranes was determined by measuring the release of inorganic phosphate from 5 mM ATP in the presence of 10 mM MgCl 2 , 5 mM sodium azide, 1 mM ouabain, and 0.5 mM EGTA and in the presence and absence of 0.3 mM sodium orthovanadate (26, 35) .
Data Analysis-Equations 1-3 were used to obtain the best fit curves by using the program SIGMA PLOT (Jandel, Inc.), which uses the Marquard-Levenburg algorithm.
RESULTS
Using FACS, we first studied binding of P-gp-specific monoclonal Ab UIC2 to cells of various cell lines engineered to express human P-gp. , with a higher dose (600 ng/ml; N3-600), and with a still higher dose (2400 ng/ml; N3-2400), as well as the MDR1 Gly-185 cell strain grown in the presence of 60 ng/ml colchicine (see panel B). In each case, the data are plotted as the number of cells on the ordinate that are labeled with the fluorescence intensity denoted on the abscissa. Cells tested with the control IgG Ab showed very little fluorescence with no increase as the concentration of Ab is raised, whereas the Gly-185 and Val-185 strains, tested with monoclonal Ab UIC2, demonstrate a clear and similar fluorescence signal that increases in intensity as the concentration of Ab increases. The various cell strains depicted in panel D show a marked difference in signal intensity, consistent with differences in the amount of P-gp present on the surface of these different cells (24) .
To determine the number of available P-gp molecules on the cell surface, we used the same monoclonal Ab UIC2 and a depletion assay. We first quantitate how the degree of reaction depends on the amount of Ab. /reaction at 4°C. We fitted the data by the simple binding equation.
where [Ab] is the concentration of the Ab present in the reaction sample, BOUND is the measured median fluorescence due to binding of Ab to the cells, BOUND MAX is the maximum fluorescence determined by the maximum Ab bound to the amount of cells present, while K m is the concentration of Ab that gives one-half maximal binding (a measure of the affinity of Ab for ligand, here P-gp). Next, we titrated the Ab, present at an amount less than the values of K m found in the previous titrations, against an increasing number of added cells, using up to 8 million cells/reaction sample. As the number of cells per sample increases, less and less Ab is available for each cell. The median fluorescence per cell decreases as Ab is depleted from the reaction mixture by being bound to the cells themselves. We fitted the data by the depletion equation.
where [Cells] is the number of cells present per reaction sample, BOUND is the measured median fluorescence due to binding of Ab to cells, BOUND init is the initial fluorescence determined by the maximum Ab bound per cell at the weight of Ab present, while K n is that number of cells that depletes by one-half the maximal amount of binding (a measure of the number of sites that bind the Ab, i.e. of P-gp molecules per cell). For the Gly-185 cells, we found K m to be 1.87 Ϯ 0.24 g of Ab, while K n was 2.97 Ϯ 0.77 million cells/reaction sample. We calculate the number of P-gp molecules exposed to Ab as follows. In For the Val-185 3T3 cells, similarly, the number of P-gp sites per cell is 2.63 Ϯ 0.87 million, not significantly different from the number present per Gly-185 3T3 cell. We performed the same experiments also for the N3-2400 strain of human MDR1-transfected 3T3 cells (see Ref. 24 and Fig. 1D ). For these cells (data not shown), the value of K m was found to be 2.9 Ϯ 0.4 g of Ab while K n was 0.56 Ϯ 0.14 ϫ 10 6 cells. Calculating, as described above, gives 14.2 Ϯ 3.8 ϫ 10 6 molecules of P-gp/cell for this highly resistant strain.
In addition, with the MDR1 Gly-185-transfected 3T3 cells, we used another human P-gp-specific monoclonal Ab with an external epitope, MRK-16 (27) , and also the Fab and F(abЈ) 2 fragments prepared from this Ab. The depletion titration gave a K n value of 1.90 Ϯ 0.37 ϫ 10 6 cells for the MRK-16 Ab and 2.76 Ϯ 0.62 ϫ 10 6 for the F(abЈ) 2 fragment, not significantly different. Similar results were obtained with Fab (monovalent) fragment (data not shown). Considering these data it is reasonable to assume that 1 molecule of Ab binds to 1 P-gp molecule.
P-gp can act on its substrates in two ways; it can pump drug from the cytoplasm of the cell and also pump it out from the membrane before it reaches the cytoplasm (19) . We determined the maximum rate of VBL pumping by P-gp by these two pathways. First, we studied the extraction of VBL from the membrane before it accumulated inside the cell. Fig. 3 shows the time course of uptake of VBL into Gly-185 3T3 cells at 37°C in PBS. (In Figs. 3 and 4 , the ordinate is the amount of VBL taken up and expressed as the volume of external medium cleared of VBL (in l) per million cells at the time stated (19) . Multiplying this measure by the concentration of VBL in the external medium would give the amount of VBL that enters the cell in the given time period). In Fig. 3A , the time course was measured over an extended range. The final level of uptake is dramatically increased by adding 50 M of the reverser verapamil to the cells (filled circles). In Fig. 3B , however, uptake is measured for 12 s at 37°C. Uptake is linear from zero time during this interval. In succeeding experiments, uptakes were performed at 10 s in the initial rate range. Fig. 4A depicts the uptake of VBL during 10 s in the presence (filled circles) and absence (open squares) of 50 M verapamil. In the presence of verapamil there is little change in the VBL uptake as the concentration of the drug is increased. In its absence, uptake increases with the concentration of VBL. Two curves, with and without verapamil, begin to approach one another, which is consistent with increasing concentrations of VBL saturating the pumping ability of P-gp so that it cannot cope with the inflow of the drug. Thus, the difference between uptake of VBL in presence and absence of verapamil gives the component of pumping that takes place as the drug crosses the membrane but before it enters the cytoplasm (18, 19) . In Fig. 4B we plot this difference, i.e. pumping of VBL by P-gp, as a function of [VBL] by combining data from different experiments. The filled circles are from Fig. 4A , open circles are from a similar experiment at other concentrations of VBL, whereas the open square is from the 10-s data points of Fig. 3B . The ordinate here, the volume of external medium cleared at the time chosen, is proportional to the velocity of uptake (v) divided by the concentration of VBL in the external medium (S). Using MichaelisMenten kinetics to describe the pumping action of P-gp leads us to
where V max is the maximum velocity of pumping (in moles/cell/ second), whereas K p is that [VBL] giving one-half maximum pumping velocity. We fitted the data of Fig. 4B to Equation 3 where v/S is the uptake of VBL (volume of external medium cleared per 10 s) and obtained an estimate of K p and V max . We
FIG. 2. Titration of cell surface P-gp against increasing amounts of UIC2 Ab (panels A and C) or against increasing numbers of cells added (panels B and D).
In panels A and B, cells were NIH3T3 transfected with wild-type (Gly-185) MDR1, whereas in panels C and D, these were the mutant Val-185 transfectants. In each case the ordinate is the median fluorescence from an experiment, as depicted in Fig. 1 We next studied zero trans-efflux (28) from cells loaded with VBL. In Fig. 5A , Gly-185 3T3 cells were loaded with 1.4 nM VBL at 25°C for 40 min in the presence of 10 mM sodium azide and 10 mM 2-deoxyglucose to deplete the energy (19) . (These experiments were performed at 25 rather than 37°C since we found that during loading of the cells at 37°C, in the absence of an energy source, they became less adherent to the dishes, preventing an accurate determination of efflux rates.) Cells were washed rapidly with ice-cold PBS and then exposed to a washout medium at 25°C, free of VBL but containing either PBS ϩ 10 mM sodium azide ϩ 10 mM 2-deoxyglucose (filled circles) or PBS ϩ 5 mM glucose to restore energy (filled squares). The data were fitted by an exponential efflux equation, giving values for t 1/2 of 37 and 4.4 min into azide/2-deoxyglucose or glucose medium, respectively. Efflux into glucose medium is thus some 8ϫ that into azide/2-deoxyglucose. A parallel experiment performed with [VBL] at 100 M is depicted in Fig. 5B . Rates into azide/2-deoxyglucose and glucose are now similar to t 1/2 values of 13 and 8.4 min, respectively. In addition, results of similar experiments with different concentrations of VBL are depicted in Fig. 5C . Here we plot efflux during 2 min, reported as the difference between efflux into glucose and into azide/2-deoxyglucose and expressed as a fraction of the zero time value, as a function of [VBL] . Data from Fig. 5, A and B are shown as open squares with circles being from another experiment and triangles from a third. As for Fig. 4B , we fitted these data by Equation 3 , obtaining a value for the maximum velocity of pumping (fractional loss) as 0.179 Ϯ 0.011/min. The volume of external medium cleared by 10 6 cells at zero time of efflux was 21.5 Ϯ 1.5 l (n ϭ 5). The K p from Fig. 5C was 15.1 Ϯ 3 .0 M. Thus, at a concentration of VBL in the external medium equal to K p , there would be 21.5 ϫ 15.1 or 325 pmol of vinblastine present within the cell. This is pumped out at one-half the maximum rate but represents one-half of the pumping capacity of the cell's P-gp. Thus the maximum rate of VBL efflux is 0.179 ϫ 325 pmol/10 6 cells/min or 0.59 Ϯ 0.12 ϫ 10 6 molecules/ cell/s at 25°C.
To compare these results with the turnover number for the ATPase, we measured the ATPase activity both at 25 and 37°C. We determined this activity for the Val-185 3T3 cell line and the N3-2400 cell line that is enriched for P-gp (24) . We assessed the effect of the drugs such as vinblastine, verapamil, and colchicine on stimulation of the ATPase activity (Table I) . The VBL-stimulated ATPase activity is reduced 4.63-fold as the temperature is decreased from 37 to 25°C. Were this ratio to be appropriate for the pumping function of P-gp on VBL, one would conclude that a maximum efflux of 0.59 at 25°C might be equivalent to a value of 2.73 Ϯ 0.55 ϫ 10 6 molecules/cell/s at 37°C or to a turnover number of 1.40 Ϯ 0.43 s
Ϫ1
, which is indistinguishable from the value determined for the inward component of pumping (Fig. 4B ).
DISCUSSION
Our data provide an estimate of the number of P-gp molecules present at the surface of the cell by using an antibody depletion method. The number we find for both Gly-185 MDR1-and Val-185 MDR1-transfected cell lines appears reasonable in light of the previous determinations. Thus, Pastan et al. (29) , using MRK-16 Ab and ferritin bridge labeling, determined that MDR1 virus-infected colchicine-resistant MDCK cells express about 5.5 ϫ 10 6 P-gp molecules/cell. Sehested et al. (30) , using freeze-fracture electron microscopy found 500 P-gp molecules/ m 2 of plasma membrane, corresponding to 8 ϫ 10 5 molecules/ cell. Shapiro and Ling (12) estimated that multidrug-resistant Chinese hamster ovary cells contain 3 to 4 ϫ 10 6 P-gp molecules/cell based on the yield of purified P-gp from these cells. Although, we compare different cell lines with different degrees of drug resistance, our estimates of 2 ϫ 10 6 molecules of P-gp for the Gly-185 3T3 cells, 2.6 ϫ 10 6 for the Val-185 cells, and 14 ϫ 10 6 for the highly resistant N3-2400 cells are compatible with previous data. The Ab depletion method has the advantage of giving an in situ determination of the number of Abbinding molecules per cell and requires no assumptions as to the yield of protein extracted from the plasma membrane or the yield of membranes that can be prepared from the whole cells.
Our data on the maximum velocity of drug efflux can be compared with two values in the literature. Ghauharali et al. (31) studied daunorubicin efflux from multidrug resistant human KB-8 -5 epidermoid carcinoma cells using a fluorescence assay and reported a maximum efflux of 180 pmol of daunorubicin/10 6 cells/min at 37°C to be compared with 58 pmol/min/ 10 6 cells at 25°C in our study or perhaps 4.63ϫ this value (269 pmol/10 6 cells/min) if we take the temperature dependence of the ATPase activity as appropriate for pumping. A far higher value of 2,000 pmol/min/10 6 cells was calculated by Stein (18) from data reported by Nielsen et al. (32) for daunorubicin efflux from the multidrug resistant Ehrlich ascites tumor cells. The reason for this discrepancy is not clear, but these experiments were not designed to determine the maximum value for daunorubicin pumping. The higher value for daunorubicin efflux (2 nmol/min/10 6 cells) gives rise to a higher drug/ATP stoichiometry in the calculations of Stein (18) .
We can compare the turnover numbers that we obtain on combining our transport data and the estimates of the number of P-gp molecules per cell with the turnover numbers that are available for the purified protein (12) , these being in the range 1-10/s. Urbatsch et al. (13) , using purified P-gp from drug resistant Chinese hamster ovary cells report a turnover number of 4.9 s Ϫ1 for the basal ATPase activity and 9.2 s Ϫ1 for the activity in the presence of verapamil. The verapamil-stimulated activity would thus have a turnover number of 4.3 s
Ϫ1
. Our data 2 (see also Table I ) using purified and reconstituted . It is difficult to know which of these turnover numbers are appropriate to compare with the turnover numbers for VBL pumping (1.1-1.4 s
) that we have determined. In addition, our data for VBL efflux necessarily had to be determined at 25°C whereas the values for the turnover number of the ATPase activity have been determined at 37°C. We did, however, also measure ATPase activities at 25°C for all the P-gp species that we studied for three different drugs that stimulate the activity of P-gp (Table I ). In particular, the ATPase activity in the presence of verapamil and VBL was reduced 3.5-and 4.6-fold, respectively, as temperature was reduced from 37 to 25°C, comparable with the reduction of 3.6-fold found in the two determinations of the VBL pumping rates in Gly-185 cells.
Our turnover numbers for VBL pumping may be underestimated. In particular, we measured pumping rates in the living cell at prevailing ATP concentrations. The K m for ATP for P-gp ATPase is reported as being in the range 0.28 -1.4 mM (10, 12)). With intracellular ATP concentrations being some 2 mM, P-gp may be operating at only one-half of its maximum activity, especially in our experiments on VBL efflux, where the drug is loaded into cells in the absence of an energy source, glucose is added at zero time, and VBL efflux is measured from that time. Some time may be required for ATP concentration to reach a fully saturating level so that our turnover number of 1.4 s Ϫ1 (corrected for temperature) could well underestimate the true value.
There is no reason, however, to suggest that a large number of ATP molecules are required to expel a single molecule of VBL. The stoichiometry between VBL pumping and ATP hydrolysis seems to be of order of magnitude unity, but direct estimations of the ATP consumption by P-gp, concomitant with drug transport, will be needed to establish this. Such direct measurements have been made for a bacterial periplasmic binding protein-dependent transport system (also a member of the superfamily of ABC transporters), where a stoichiometry of almost 2 ATP molecules hydrolyzed per substrate molecule transported has been established (33) .
Finally, we address the question of whether the pumping activity of P-gp, computed from the turnover number for drug pumping taken together with the number of P-gp molecules per cell, can account for the high levels of drug resistance that are found. Our data show that these numbers are perfectly compatible with the resistance parameters. We argue above that the turnover numbers that we find for drug pumping are compatible with those reported for the drug-stimulated component of the ATPase activity of P-gp. We now argue that the pump rates that we measure are compatible with the level of drug resistance. Consider first the rate of efflux pumping of VBL (Fig. 5A) . The efflux rate in the presence of an active P-gp system is 8ϫ the rate in its absence. Second, consider the numbers for the effect of P-gp on reducing the inward movement of VBL (Fig. 4A) . Here P-gp reduces 3-fold the inward flow of VBL. Taken together, these two effects should bring about a reduction of 3 ϫ 8 ϭ 24-fold in the internal [VBL] compared with the level in the absence of an effective P-gp pumping system. The VBL resistance of Gly-185 MDR1-(wild type) transfected 3T3 cell line is 46-fold times the resistance of the recipient 3T3 drug-sensitive strain (34) . Thus, the presence of P-gp acting as a drug pump with the kinetic properties revealed in this study is sufficient to account for by far the major part of the P-gp-induced drug resistance that can be measured. Interestingly, the N3-2400 cell line has a drug resistance against VBL that is 4 or 5ϫ greater than that of the Gly-185 and Val-185 cell lines. Our analysis suggests that the number of available P-gp molecules on the surface of the N3-2400 cells is 5-7ϫ as high as for the Gly-185 and Val-185 lines, commensurate with the increase in drug resistance. a Each column is for the strain of MDR1-transfected 3T3 cells as indicated at either 37 or 25°C. The data are reported as nmol of P i released per min/mg of protein.
b At this concentration, vinblastine inhibits activity in this mutant.
